Today, on the 80th anniversary of bicycle day, Psygen announces the successful production of 1.5 million microdoses of GMP LSD. The Psygen team is 99.98% sure this LSD is of the highest quality available for clinical use.
To learn more: https://t.co/FEkvBsqHTt
#BicycleDay
We are honored to be nominated for 3 awards this year at The Second Annual Microdose Awards:
-LSD Company of the year
-MDMA Company of the year
-Ibogaine Company of the year
Please vote for us by October 31 at: https://t.co/iuIBVFjZCl
#psychedelics#psychedelicresearch
Danny Motyka, Psygen's CEO, is joining a panel of Canadian Psychedelic leaders to discuss: “The Future of Psychedelic Use and Research in Canada” at the Grow Up Psychedelic Summit on June 20 in Victoria, BC!
To learn more: https://t.co/B7M9sMczyz #psychedelics#psychedelics
Psygen is honored to have some special visitors today!
Dr. David Nichols and Cibele Nichols toured our new facility here in Calgary.
#Psygen#psychedelics#psychedelicresearch
Join @SabiMind Thu Jun 16 from 6-7pm MDT for the preliminary results from the Canadian Psychedelic Survey (CPS), the most comprehensive assessment of national psychedelic use amongst Canadians to date co-sponsored by Psygen.
Register here: https://t.co/pCRWH9iPVq
#psychedelics
We are proud to join forces with Canadian psychedelic medicine and therapy companies from across the country to fulfill the promise of psychedelic molecules as therapeutic treatments. @PsychedelicsCAN
Learn more: https://t.co/BcVfxAXR0J
#psychedelicmedicine#psychedelics#canada
We are thrilled to announce our title sponsorship of MAPS Psychedelic Science 2023! We look forward to co-creating an impactful conference experience at one of the largest #psychedelic conferences in history. See you at the immersive Psygen booth! #psygen@MAPS@PsychedelicSci
Meet the man making synthetic psychedelics - for research & beyond
Here is what we learned from Peter van der Heyden - CSO @psygenltd - about producing psychedelics for research & at scale
Read the full interview with Peter on Blossom 👇 https://t.co/67sMb4ipQW
Join us at ICPR 2022, the leading psychedelic research conference in Europe by @OPEN_fndn. We look forward to discussing rigorous science, critical perspectives, and psychedelic therapy with industry leaders on Sep 22-24 in Amsterdam. Use code PSYGEN100 for €100 discount.
Health Canada clarifies need for GMP compliance of naturally-sourced psilocybin. Natural products will be held to the same standard as synthetic products and will face hurdles that are avoided by Synthetic Products.
Full article: https://t.co/mnKqVjZ1oP
#psilocybin#psychedelic
@psyinvest Launches New #Podcast 🎙️
Season 1 includes interviews with the following industry professionals:
@ChemWit CEO of @psilera Bioscience
NaneaReeves CEO of @TRIPPVR
Danny Moytyka CEO of @psygenltd
Hadas Alterman Founding Partner at @law_plant
https://t.co/1NfYczYR1o
Psygen is honored to be a part of this moment, the first occasion in which patients have received access to psilocybin through the SAP.
We are grateful for @TheraPsil, Roots to Thrive, and Dr. Valorie Masuda for leading this endeavor.
https://t.co/qdOUk6qGwq
#psychedelictherapy
A Vancouver Island doctor is among the Canadian physicians leading the way on researching and prescribing psychedelic-assisted therapy.
https://t.co/fAmhYgypvN